Scientists have welcomed the "extremely encouraging" results of Janssen's new single-shot Covid-19 vaccine trial announced less than 24 hours after the Novavax jab also appeared effective.

The vaccine, developed by the Johnson & Johnson-owned pharmaceutical firm, is 66% effective overall at preventing moderate to severe coronavirus 28 days after vaccination, trial results show.

Novavax announced late on Thursday that its jab was 89% effective following a clinical trial run in the UK.

The data per 100,000 people for the seven-day average.

For each area the figures are as follows:

Allerdale - 390.7

Barrow - 344.5

Carlisle - 504.2

Copeland - 330

Eden - 304.2

South Lakes - 221.7

The total number of people with at least one positive Covid-19 test result (either lab-reported or lateral flow device) since the start of the pandemic in each area:

Allerdale - 4,169.4

Barrow - 5,422.9

Carlisle - 6,898.4

Copeland - 3,706.2

Eden - 5,008.2

South Lakes - 3,853